Belgium· BE-AMP-SAM233265-00

Clinoleic 20 %

A fettemulsionen product containing glycine soja siebold et zucc. - glycine max merr. (ph.eur. mixture) 20% + olea europaea l. 80%, oil - refined, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedClinoleic 20 %ATCB05BA02REGISTER NO.BE-AMP-SAM233265-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Glycine soja Siebold et Zucc. - Glycine max Merr. (Ph.Eur. mixture) 20% + Olea europaea L. 80%, Oil - Refined
Manufacturer
Baxter
Country
Belgium (BE)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

  • be_apb
    1480466
  • be_apb
    0760827
  • be_apb
    1480474
  • be_apb
    0760835

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b67f9c52-a105-429e-902c-5ff6600e17a5
GET /v1/drugs/b67f9c52-a105-429e-902c-5ff6600e17a5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Clinoleic 20 %",
  "name_fr": "Clinoleic 20 %",
  "name_nl": "Clinoleic 20 %",
  "amp_code": "SAM233265-00",
  "strengths": [
    "200.0000",
    "22.5000",
    "0.3000"
  ],
  "pack_count": 14,
  "substances": [
    "Glycine soja Siebold et Zucc. - Glycine max Merr. (Ph.Eur. mixture) 20% + Olea europaea L. 80%, Oil - Refined",
    "Glycerol",
    "Sodium Hydroxide",
    "Sodium Oleate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fat Emulsions",
  "authorisation_numbers": [
    "BE233265",
    "BE233274",
    "BE233283",
    "BE233292",
    "BE233301"
  ]
}

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.